Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	IDXXIdexx Laboratories	BDXBecton Dickinson	EWEdwards Lifesciences
Snapshot
Price	$523.53	$182.60	$89.23
Market cap	$44.00B	$43.56B	$54.34B
Valuation
P/E	37.7x	44.4x	46.8x
Forward P/E	30x	59.1x	66.9x
Growth
Revenue growth	13.1%	2.4%	13.8%
EPS growth	25.6%	-24.8%	-73.2%
Profitability
Net margin	24.6%	5.3%	17.4%
ROE	70.9%	4.5%	10.6%
Balance sheet & cash
Debt / equity	0.53x	0.76x	0.06x
Free cash flow yield	1.9%	9.0%	2.9%
Dividend yield	—	2.9%	—
Verdict
Investment rating	Favorable· 69	Weak· 32	Neutral· 47

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	IDXXtoday $524	BDXtoday $183	EWtoday $89
2027	$493.13 – $723.25+38% CAGR	$139.69 – $204.88+12% CAGR	$68.26 – $100.12+12% CAGR
2028	$619.32 – $908.33+32% CAGR	$142.48 – $208.97+7% CAGR	$69.63 – $102.12+7% CAGR
2029	$777.80 – $1,140.77+30% CAGR	$145.33 – $213.15+5% CAGR	$71.02 – $104.16+5% CAGR
2030	$976.84 – $1,432.70+29% CAGR	$148.24 – $217.42+4% CAGR	$72.44 – $106.24+4% CAGR
2031	$1,226.81 – $1,799.32+28% CAGR	$151.20 – $221.77+4% CAGR	$73.89 – $108.37+4% CAGR
5-yr CAGR	18.6% – 28.0%	-3.7% – 4.0%	-3.7% – 4.0%